Segall Bryant & Hamill LLC Buys 3,948 Shares of Ingevity Corporation $NGVT

Segall Bryant & Hamill LLC lifted its stake in shares of Ingevity Corporation (NYSE:NGVT) by 0.3% in the second quarter, HoldingsChannel.com reports. The institutional investor owned 1,283,210 shares of the company’s stock after buying an additional 3,948 shares during the quarter. Ingevity comprises about 0.8% of Segall Bryant & Hamill LLC’s investment portfolio, making the stock its 12th biggest position. Segall Bryant & Hamill LLC’s holdings in Ingevity were worth $55,294,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of NGVT. PNC Financial Services Group Inc. raised its holdings in Ingevity by 2.4% in the 1st quarter. PNC Financial Services Group Inc. now owns 12,389 shares of the company’s stock valued at $490,000 after acquiring an additional 292 shares during the period. BI Asset Management Fondsmaeglerselskab A S grew its position in shares of Ingevity by 21.6% in the first quarter. BI Asset Management Fondsmaeglerselskab A S now owns 1,670 shares of the company’s stock valued at $66,000 after purchasing an additional 297 shares during the last quarter. Savant Capital LLC increased its stake in shares of Ingevity by 0.4% during the second quarter. Savant Capital LLC now owns 85,335 shares of the company’s stock worth $3,677,000 after purchasing an additional 313 shares during the period. Inspire Investing LLC lifted its holdings in Ingevity by 4.1% during the 2nd quarter. Inspire Investing LLC now owns 9,038 shares of the company’s stock worth $389,000 after purchasing an additional 358 shares during the last quarter. Finally, Empowered Funds LLC boosted its stake in Ingevity by 12.9% in the 1st quarter. Empowered Funds LLC now owns 5,181 shares of the company’s stock valued at $205,000 after purchasing an additional 594 shares during the period. Institutional investors and hedge funds own 91.59% of the company’s stock.

Ingevity Stock Performance

NGVT opened at $49.60 on Friday. The company has a debt-to-equity ratio of 10.24, a quick ratio of 0.80 and a current ratio of 1.36. Ingevity Corporation has a 52-week low of $28.49 and a 52-week high of $60.77. The firm has a market cap of $1.78 billion, a P/E ratio of -8.34 and a beta of 1.45. The business’s fifty day moving average is $53.61 and its 200-day moving average is $49.47.

Ingevity (NYSE:NGVT) last posted its quarterly earnings data on Friday, March 24th. The company reported $0.78 earnings per share for the quarter. Ingevity had a negative net margin of 16.35% and a positive return on equity of 84.92%. The business had revenue of $336.00 million during the quarter. Sell-side analysts expect that Ingevity Corporation will post 4.45 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have weighed in on the company. BMO Capital Markets increased their price objective on Ingevity from $62.00 to $68.00 and gave the stock an “outperform” rating in a research report on Friday, September 5th. Wall Street Zen raised shares of Ingevity from a “buy” rating to a “strong-buy” rating in a research report on Saturday, August 9th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Ingevity in a research note on Wednesday, October 8th. Finally, Wells Fargo & Company boosted their price objective on shares of Ingevity from $52.00 to $55.00 and gave the company an “equal weight” rating in a report on Wednesday, November 12th. One equities research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $61.50.

Ingevity Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.